Cipla signs pact with Teva for selling drugs in S Africa - BusinessToday
Teva Launches Generic Amikin Injection - MPR
United Kingdom first to grant licence for Teva's ophthalmology biosimilar Ongavia (ranibizumab)▽
United Kingdom first to grant license for Teva's ophthalmology biosimilar Ongavia
Ophtal tekutina oční 2 x 50ml - Příbalový leták | Pilulka.cz
Teva Receives Marketing Authorization in Europe for Lucentis Biosimilar Ranivisio - Eyewire+
Teva Receives FDA-Approval for Smartphone-Linked Digital Inhaler - Docwire News
EpiPen litigation comes back to haunt Teva
00093321915 - Henry Schein Medical
Teva wins U.K. approval for Lucentis biosimilar (NYSE:TEVA) | Seeking Alpha
USFDA warns of Teva Pharma ADHD drug Adderall shortage
Teva Reports Third Quarter 2022 Financial Results
Ophtal oph.aqa 4x25ml plast - GigaLekáreň.sk
Teva launches generic version of Celebrex caps | Drug Store News
Voda oční Ophtal Teva, Teva Pharmaceuticals | Kupi.cz
Teva joins forces with Icelandic firm to gain edge on biosimilars | The Times of Israel
OPHTAL - ADC.sk
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Teva refiles NDA for schizophrenia treatment
Teva's flagship drug Austedo scores new approval at the FDA
Teva's Huntington drug launch on hold after FDA rejection | Fierce Biotech
OPHTAL - ADC.sk
Global Ophthalmology Therapeutics Market 2023-2027
